Currently, regenerative medicine targeted at dogs is being conducted as

The company ACTE (Advanced Cell Technology and Engineering Co.) stores

Currently, about 60% of the cost for hydrogen used in

According to a lecture of a MHLW representative, the total

Other targets are cerebral infarction, deep white matter infarction, perinatal

6 scaffold-free conduits from human normal dermal fibroblasts were produced

The anticancer drug TRK-950, an antibody against a target discovered

The division will comprise Fujifilm Diosynth Biotechnologies USA, Inc., FUJIFILM

Nobuyuki NOBISAWA and Hiroyuki OTA of the Tokyo Institute of